Q54-19700-89246

4 vaccinations 1 coded response 42 check-ins 0 free-text entries 1 call case

Sex: Female
Age at first dose: 31-35
ZIP prefix: 980 / WA
Registered: 2021-04-17

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

AV4-37835-27115 Child or adolescent in my care · Female · 2022-06-22

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2561409 (opens in a new window)	high	10 / 11	—	4 of 15 VAERS symptoms	same dose (4)	WA matches	2022-10-17 / 2023-01-03 / 2023-01-17 received the same day as the last call	case 69276

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-16
Dose 1 — Pfizer-BioNTech
2021-04-17
Registered in v-safe
2021-04-17
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-04-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-23
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-04-30
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-05-07
Dose 2 — Pfizer-BioNTech
2021-05-07
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work

Adult check-in
2021-05-08
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-05-09
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-14
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-28
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-06-04
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-06-11
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-18
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-08-06
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-05
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-11-08
Dose 3 — Pfizer-BioNTech
2021-11-09
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school

Adult check-in
2021-11-11
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-11-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-13
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-15
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-22
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-29
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-06
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-13
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-20
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-07
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-10-17
Dose 4 — Pfizer-BioNTech
2022-11-08
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in
2022-11-08
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-11-14
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-11-21
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-11-28
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in
2023-01-16
Survey response — 3 months, dose 4
MedDRA: Cough, Ear pain, Nasopharyngitis, Ocular hyperaemia, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-01-16
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-01-17
Call 1 — Left Voicemail
2023-01-17
Call successful
Completed over the phone
2023-04-17
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-16	Pfizer-BioNTech
2	2021-05-07	Pfizer-BioNTech
3	2021-11-08	Pfizer-BioNTech	No
4	2022-10-17	Pfizer-BioNTech	No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Ear pain	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Ocular hyperaemia	·	·	✓
SD	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release